SmartBreast Forms Molecular Breast Imaging Partnership with FITI
February 9, 2021 After acquiring the molecular breast imaging (MBI) assets from GE Healthcare and Dilon Technologies, Inc., SmartBreast Corporation (SmartBreast), a privately held company focused on breast cancer screening and diagnosis, announced today that it has formed a partnership with FoxSemicon Integrated Technologies, Inc. (FITI) to manufacture molecular breast imaging (MBI) systems.
FITI has invested substantially in SmartBreast and will be the contract manufacturer for two MBI systems recently acquired by SmartBreast: the GE Healthcare Discovery NM 750b and the Dilon Technologies D6800. SmartBreast will rebrand the two systems as EVE CLEAR SCAN e750 and e680, respectively. Together, SmartBreast and FITI will co-develop and manufacture innovative, cost-effective, next-generation MBI systems to further increase the efficacy of detecting cancer in the earlier stage. We will integrate stereotactic MB
Press release content from PR Newswire. The AP news staff was not involved in its creation.
SmartBreast™ Acquires Molecular Breast Imaging Assets from GE Healthcare
February 8, 2021 GMT
PITTSBURGH, Feb. 8, 2021 /PRNewswire/ SmartBreast Corporation (SmartBreast™), a privately held company focused on breast cancer screening and diagnosis, announced today that it has acquired the Discovery NM750b Molecular Breast Imaging (MBI) assets from GE Healthcare, including the MBI scanner designs, manufacturing tools, instructions, related patents and the installed-base service business.
The Discovery NM750b is installed at scores of sites worldwide. SmartBreast will manufacture, market and distribute the MBI scanner, rebranded as “EVE CLEAR SCAN e750.”
SmartBreast™ Acquires Molecular Breast Imaging Assets from Dilon Technologies®
News provided by
Share this article
PITTSBURGH, Dec. 29, 2020 /PRNewswire/
Smart Breast Corporation (SmartBreast™), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain Molecular Breast Imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount.
Dilon D6800 MBI scanner acquired by SmartBreast.
Comparison of mammogram in dense breast tissue that appeared “normal” and the MBI scan which detects a hidden early stage invasive cancer (courtesy of Mayo Clinic).
The acquired MBI technology sees through dense breast tissue to find 3 to 4 times more cancers than mammography alone.